HLA-A (Human Leukocyte Antigen A Typing)

Human Leukocyte Antigen A (HLA-A) typing is a specialised genetic test that identifies the specific variants of the HLA-A gene you carry. HLA-A is part of the major histocompatibility complex (MHC) and plays a central role in how your immune system recognises your own cells and distinguishes them from foreign threats such as viruses, bacteria, and tumour cells. This test is relevant for individuals undergoing organ or stem cell transplant assessment, those investigating certain autoimmune or inflammatory conditions, and anyone seeking to understand their inherited immune profile. It is also used in pharmacogenetics to assess risk of severe drug hypersensitivity reactions associated with specific HLA-A alleles.

The test is performed using PCR-hybridisation, a highly sensitive molecular technique that amplifies and probes specific HLA-A gene sequences to determine your allele type with precision.

Markers included

• HLA-A Typing: Identifies the specific HLA-A alleles present in your genome. This includes common variants such as HLA-A02, HLA-A01, HLA-A03, HLA-A11, HLA-A*24, and others. Each allele encodes a distinct cell-surface protein that influences immune recognition, transplant matching, and susceptibility to certain immune-mediated diseases or drug reactions.

Why it matters

Knowing your HLA-A type provides valuable insight into your immune system's genetic blueprint. It can inform transplant compatibility, guide safer medication choices, and help clarify inherited predisposition to certain autoimmune or inflammatory conditions. For clinicians, this information supports precision medicine decisions and risk stratification. For patients, it offers a deeper understanding of their own biology and can be a critical piece of the puzzle when investigating complex immune-related health concerns.